Cigna settles FTC insulin case, aims to lower drug prices
By Jody Godoy Feb 4 (Reuters) – Cigna Corp’s Express Scripts settled the U.S. Federal Trade Commission’s claims its insulin pricing practices violated antitrust and consumer protection laws, and agreed to changes aimed at lowering costs for patients, …